The Design and Evaluation of Clinical Pathway for Disease Management to Maximize Public Health Benefit
Shuanghong Luo,Chuncheng Wu,Qiuhong Luo,Mengdong Ran,Yin Liu,Fei Lei,Xin Chen,Zheng Yuan,Hanmin Liu,Chaomin Wan
DOI: https://doi.org/10.2147/RMHP.S340718
2021-12-18
Risk Management and Healthcare Policy
Abstract:Shuanghong Luo, 1, 2 Chuncheng Wu, 3 Qiuhong Luo, 1, 2 Mengdong Ran, 4 Yin Liu, 5 Fei Lei, 6 Xin Chen, 7 Zheng Yuan, 8 Hanmin Liu, 1, 2 Chaomin Wan 1, 2 1 Department of Paediatrics, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China; 2 Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, People's Republic of China; 3 Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, People's Republic of China; 4 Department of Biostatistics, West China Women & Children Union Doctor, Chengdu, People's Republic of China; 5 Research and Development Department, West China Women & Children Union Doctor, Chengdu, People's Republic of China; 6 Medical Information Center, West China Women & Children Union Doctor, Chengdu, People's Republic of China; 7 Child Health Care Department, Nanxin Community Health Service Center, High-Tech Zone, Chengdu, People's Republic of China; 8 Economics School, Southwestern University of Finance and Economics, Chengdu, People's Republic of China Correspondence: Chaomin Wan Tel/Fax +86-28-85503185 Email As an implementation strategy, the actual functional scope of clinical pathway (CPW) can be mastered is the basis for evaluating and improving CPW management, which is very important for bridging the evidence-to-practice gap. Here, we propose and discuss a design and evaluation model for CPWs through some theoretical lenses that may help the designer master the actual functional scope of CPWs and accumulate and refine effective key management steps of a specific disease. We can thus determine the best-optimized design with the largest net benefit that allows definition of the core management steps for a specific disease. Keywords: implementation science, clinical pathway, evidence-based medicine, health technology assessment, public health economics The popularization of evidence-based clinical practice guidelines improves the dissemination and application of evidence by physicians, helps improve the clinical and economic outcomes of diseases, and plays an important role in developing plans for future studies and disease management. 1 However, evidence-based clinical practice guidelines may be insufficient for bridging the evidence- or knowledge-to-practice gap. Studies have shown that more than 20 years is required to assimilate good research evidence into daily clinical practice. 2–4 The critical path method, which has been used in the manufacturing industry, was introduced into the medical industry to develop a clinical pathway (CPW) for disease management in the 1980s. Since then, evidence has been integrated into the local medical and health system, 5 becoming an important tool for governments and health organizations assumed to directly improve medical care quality, standardize medical procedures, and control medical costs. 6 An intervention is considered a CPW if it meets four criteria: 1) it is a structured multidisciplinary care plan; 2) it is used to channel the translation of guidelines or evidence into local structures; 3) it details the steps in the course of treatment or care in a plan, pathway, algorithm, guideline, protocol, or other "inventory of actions" (ie, the intervention has time frames or criterion-based progression); and 4) it aims to standardize care for a specific clinical problem, procedure, or episode of care in a specific population. 7,8 However, as an implementation strategy, CPW implementation research and improvement involve extensive complexity and numerous challenges. The implementation effectiveness of CPWs in real-world clinical settings is different from the sum treatment effectiveness of interventions involved in CPWs in relatively controlled trial environments. 9,10 When a CPW implementation effort fails, determining whether the failure occurred because one or more critical interventions of the CPW were ineffective in the new setting (intervention strategy failure) or if good interventions were deployed incorrectly (implementation strategy failure) is important. Unfortunately, we lack a theoretical understanding of CPW implementation. 10,11 All prototypes of the existing CPWs of disease management were discussed and developed by multidisciplinary teams (MDTs) and were evaluated by commonly used cohort studies or traditional efficacy- or effectiveness-oriented randomized controlled trial designs. Due to the inability to determine the actual CPW operating process, the effectiveness of CPW management can only -Abstract Truncated-
health care sciences & services,health policy & services